The CompanyNovotech provides high quality clinical development services throughout The Asia Pacific. We are the largest Australia based CRO operating in 8 countries and 15 locations regionally.Working with clients in the biotechnology, medical device, and pharmaceutical sectors, Novotech delivers the entire spectrum of regulatory, biometry, and clinical trial services, and has contributed to the development of over 120 therapeutic products by successfully delivering hundreds of projects with a combined total of more than 10,000 subjects.Novotech was established in Australia in 1996, and as a result of our continued success, has expanded into India, Korea, Malaysia, New Zealand, Singapore, Taiwan, and Thailand. We are proud of our past performance and our enviable reputation, and are committed to continued success and expansion throughout the Asia Pacific.
The CompanyNovotech provides high quality clinical development services throughout The Asia Pacific. We are the largest Australia based CRO operating in 8 countries and 15 locations regionally.Working with clients in the biotechnology, medical device, and pharmaceutical sectors, Novotech delivers the entire spectrum of regulatory, biometry, and clinical trial services, and has contributed to the development of over 120 therapeutic products by successfully delivering hundreds of projects with a combined total of more than 10,000 subjects.Novotech was established in Australia in 1996, and as a result of our continued success, has expanded into India, Korea, Malaysia, New Zealand, Singapore, Taiwan, and Thailand. We are proud of our past performance and our enviable reputation, and are committed to continued success and expansion throughout the Asia Pacific.
The CompanyNovotech provides high quality clinical development services throughout The Asia Pacific. We are the largest Australia based CRO operating in 8 countries and 15 locations regionally.Working with clients in the biotechnology, medical device, and pharmaceutical sectors, Novotech delivers the entire spectrum of regulatory, biometry, and clinical trial services, and has contributed to the development of over 120 therapeutic products by successfully delivering hundreds of projects with a combined total of more than 10,000 subjects.Novotech was established in Australia in 1996, and as a result of our continued success, has expanded into India, Korea, Malaysia, New Zealand, Singapore, Taiwan, and Thailand. We are proud of our past performance and our enviable reputation, and are committed to continued success and expansion throughout the Asia Pacific.